Ireland
--:--IST
Priya Life Science Sponsor trial record
Sponsor · clinical trials

NORCE Norwegian Research Centre AS clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Norway, Austria, Spain, Italy, Poland, Switzerland and Israel registers with NORCE Norwegian Research Centre AS as lead sponsor. Synced 13 Nov 2026
4Current trials
2Recruiting now
0Drugs in these trials
7Trial registers
At a glance

NORCE Norwegian Research Centre AS is the lead sponsor of 4 current clinical trials in our Norway, Austria, Spain, Italy, Poland, Switzerland and Israel registers. 2 are recruiting patients now. All registered phases are Not applicable. The most-studied condition is Substance Use Disorder (SUD).

ClinicalTrials.gov trials by status

  • Recruiting250%
  • Not yet open125%
  • Active, closed125%

Trials by phase

  • Not applicable4100%
01

Clinical trials sponsored by NORCE Norwegian Research Centre AS

4 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Memory for Music: Individual Intensive Musical Training in Alzheimer's Disease
NCT06611878 · ClinicalTrials.gov ↗ · Alzheimer Disease
Not applicable Recruiting 2024-12 Austria, Norway
Fighting Addictions, Improving Lives: COmprehensive Drug Rehabilitation With Music
NCT07028983 · ClinicalTrials.gov ↗ · Substance Use Disorder (SUD)
Not applicable Recruiting 2025-07 Spain, Italy, Poland, Switzerland, Austria, Norway, Israel
Reducing School Dropout and Enhancing Pupils' Sense of Belonging and Participation Through Co-created Music-based Activities
NCT07632391 · ClinicalTrials.gov ↗ · Preventative Health, Well-Being, Psychological, Salutogenesis
Not applicable Not yet open 2026-08 Norway
Be-Prox. An Effectiveness Study of Bullying Intervention in Norwegian Kindergartens.
NCT06040437 · ClinicalTrials.gov ↗ · Bullying of Child
Not applicable Active, closed 2023-08 Norway

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in NORCE Norwegian Research Centre AS trials

7 conditions
Substance Use Disorder (SUD)1Alzheimer Disease1Bullying of Child1Preventative Health1Well-Being, Psychological1Salutogenesis1Mastery1
03

By trial register

RegisterTrialsRecruiting
Clinical trials in Norway42
Clinical trials in Austria22
Clinical trials in Spain11
Clinical trials in Italy11
Clinical trials in Poland11
Clinical trials in Switzerland11
Clinical trials in Israel11

A trial with sites in more than one country appears in each of those registers.

04

Other sponsors in Substance Use Disorder (SUD)

SponsorTrials
The Catholic University of Korea3
University of Lorraine1

Sponsors with the most current trials registered for this condition.

05

Questions about NORCE Norwegian Research Centre AS trials

How many clinical trials does NORCE Norwegian Research Centre AS sponsor?

NORCE Norwegian Research Centre AS is the lead sponsor of 4 current trials on ClinicalTrials.gov in our Norway, Austria, Spain, Italy, Poland, Switzerland and Israel registers, as of the registry sync on 13 November 2026. Completed and withdrawn studies are not counted.

Are NORCE Norwegian Research Centre AS trials recruiting?

Yes. 2 of its 4 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 13 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.